Novel Drug Approvals for 2015 (Image courtesy of jk1991 at FreeDigitalPhotos.net)
According to FierceBiotech, in 2015 Food and Drug Agency (FDA) approved 45 new drugs. It's the largest number since 1996. Here we present the summary of Big Pharma companies having last year the highest success with new drug approvals (in terms of potential sales revenue).
Number one is Novartis with 4 new drugs. Among them two blockbusters are worth to mention: Entresto (for heart failure with preserved ejection fraction) and Cosentyx for psoriasis. Only for Entresto the peak sales are estimated for more than $5 billion. The second in the stage is Sanofi with Praluent (alirocumab, PCSK9 blocking antibody) lowering LDL cholersterol and the peak sales estimate about $3 billion. Another notable high scoring companies are:
At the end of the line are Eli Lilly with approval for costly and not very effective oncologic drug Portrazza and Merck with approval for Bridion, which finally got FDA approval after three rejections.Source: www.fiercebiotech.com FDA website: Novel Drug Approvals for 2015 Image credits: jk1991Image source: FreeDigitalPhotos.net